Pacific Hospital Supply Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,406	2,345	2,320	2,185	2,019
Revenue Growth (YoY)	2.59%	1.08%	6.19%	8.23%	-7.05%
Cost of Revenue	1,667	1,598	1,580	1,597	1,495
Gross Profit	738.89	746.84	739.75	587.97	523.42
Selling, General & Admin	183.45	184.05	184.31	187.36	162.72
Research & Development	82.09	73.02	57.42	46.12	47.3
Operating Expenses	265.54	257.07	241.73	233.48	210.02
Operating Income	473.35	489.77	498.01	354.5	313.4
Interest Expense	-5.95	-6.55	-5.73	-7.03	-8.61
Interest & Investment Income	20.48	22.35	17.61	3.72	0.25
Currency Exchange Gain (Loss)	-21.42	35.86	-1.65	37.05	-38.51
Other Non Operating Income (Expenses)	9.09	16.67	20.01	19.96	17.56
EBT Excluding Unusual Items	475.55	558.1	528.26	408.19	284.09
Gain (Loss) on Sale of Assets	0.97	-1.29	-2.77	5.29	149.93
Pretax Income	476.52	556.82	525.49	413.48	434.03
Income Tax Expense	93.65	108.97	104.7	82.08	47.61
Net Income	382.87	447.85	420.79	331.4	386.42
Net Income to Common	382.87	447.85	420.79	331.4	386.42
Net Income Growth	-14.51%	6.43%	26.97%	-14.24%	17.55%
Shares Outstanding (Basic)	73	73	73	73	73
Shares Outstanding (Diluted)	73	73	73	73	73
Shares Change (YoY)	0.07%	-0.05%	0.05%	0.06%	-0.00%
EPS (Basic)	5.27	6.17	5.80	4.56	5.32
EPS (Diluted)	5.24	6.13	5.76	4.54	5.29
EPS Growth	-14.52%	6.42%	26.87%	-14.18%	17.56%
Free Cash Flow	467.83	464.13	625.83	400.96	288.34
Free Cash Flow Per Share	6.40	6.36	8.56	5.49	3.95
Dividend Per Share	4.500	5.000	4.800	4.200	4.500
Dividend Growth	-10.00%	4.17%	14.29%	-6.67%	7.14%
Gross Margin	30.71%	31.85%	31.88%	26.91%	25.93%
Operating Margin	19.67%	20.88%	21.46%	16.23%	15.52%
Profit Margin	15.91%	19.10%	18.14%	15.17%	19.14%
Free Cash Flow Margin	19.45%	19.79%	26.97%	18.35%	14.28%
EBITDA	592.45	612.87	624.99	487.38	458.58
EBITDA Margin	24.63%	26.13%	26.94%	22.31%	22.72%
D&A For EBITDA	119.1	123.1	126.98	132.89	145.18
EBIT	473.35	489.77	498.01	354.5	313.4
EBIT Margin	19.67%	20.88%	21.46%	16.23%	15.52%
Effective Tax Rate	19.65%	19.57%	19.92%	19.85%	10.97%
Revenue as Reported	-	-	-	-	2,019

Source: S&P Global Market Intelligence. Standard template. Financial Sources.